InChI=1S/C22H32O5/c1-2-3-7-12-19(23)14-10-6-11-15-20(24)13-8-4-5-9-16-21(25)17-18-22(26)27/h3-11,13-14,16,19-21,23-25H,2,12,15,17-18H2,1H3,(H,26,27)/b5-4+,7-3-,11-6-,13-8+,14-10+,16-9-/t19-,20-,21+/m0/s1 |
QBTJOLCUKWLTIC-UZAFJXHNSA-N |
C(=C/[C@@H](C\C=C/C=C/[C@H](C/C=C\CC)O)O)\C=C\C=C/[C@H](CCC(O)=O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(4S,5Z,7E,9E,11R,13Z,15E,17S,19Z)-4,11,17-trihydroxydocosa-5,7,9,13,15,19-hexaenoic acid
|
(4S,5Z,7E,9E,11R,13Z,15E,17S,19Z)-4,11,17-trihydroxydocosahexaenoic acid
|
ChEBI
|
RvD3
|
SUBMITTER
|
23608061
|
Reaxys Registry Number
|
Reaxys
|
23438740
|
PubMed citation
|
Europe PMC
|
23438748
|
PubMed citation
|
Europe PMC
|
23510485
|
PubMed citation
|
Europe PMC
|
26462421
|
PubMed citation
|
Europe PMC
|
26858146
|
PubMed citation
|
Europe PMC
|
27121596
|
PubMed citation
|
Europe PMC
|
27171898
|
PubMed citation
|
Europe PMC
|
27534559
|
PubMed citation
|
Europe PMC
|
27859331
|
PubMed citation
|
Europe PMC
|
27994074
|
PubMed citation
|
Europe PMC
|
28765512
|
PubMed citation
|
Europe PMC
|
29238967
|
PubMed citation
|
Europe PMC
|
|